Lexaria Bioscience Corp. (LEXX)
0.7588
+0.03
(+3.82%)
USD |
NASDAQ |
Jan 16, 16:00
0.7437
-0.02
(-1.99%)
After-Hours: 20:00
Lexaria Bioscience EPS Diluted (Quarterly): -0.0746 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
| ProMIS Neurosciences, Inc. | -5.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.598M |
| Total Expenses (Quarterly) | 1.595M |
| Enterprise Value | 14.17M |
| Earnings Yield | -75.70% |
| Normalized Earnings Yield | -74.53 |